Guillain-Barré Syndrome In Pregnancy
DOI:
https://doi.org/10.36408/mhjcm.v7i2.524Keywords:
Gullain Barre syndrome, pregnancy, intensive care management, SIADH, Intraveva Immunoglobulin, plasmapharesisAbstract
Background: Guillain-Barré Syndrome (GBS) is an acute demyelinating polyadiculopathy that usually present as progressive and symmetrical muscle weakness accompanied by absence or loss of deep tendon reflexes. This has been associated with various infectious agents, such as Campylobacter jejuni and usually occurs after 2-4 weeks after respiratory or gastrointestinal diseases. Estimated general incidence in population was 0.75-2: 100,000. Pregnancy can increase risk of GBS. The diagnostic criteria of GBS consist of clinical, laboratory and electrophysiological tests. Developing treatments such as plasmapheresis and intravenous immunoglobulin (IVIG) are relatively safe in pregnancy. Time and methode of delivery are based on obstetric indications and depend on maternal and fetal status.
Purpose: The condition is rare in pregnancy and only few cases have been reported in literature. Appropiate management of pregnant patients with GBS is needed.
Case report: We presented the case of a 20-year-old woman, with a 20-week pregnancy. She had experienced various complications from her GBS such as syndrome of inapropriate antidiuretic hormone secretion (SIADH), dysphagia, type 2 respiratory failure, and infectious during hospital treatment. The termination of pregnancy was carried out at 34 weeks with consideration of maternal and fetal conditions. She delivered a healthy baby.
Conclusion: GBS in pregnancy must be handled by a multidisciplinary team involving neurologists, obstetricians, internist, and anesthetists.
Keywords: Gullain Barre syndrome, pregnancy, intensive care management, SIADH, Intraveva Immunoglobulin , plasmapharesis
Downloads
References
2. Ono M, Sato H, Sirahashi M, Tomioka N, Maeda J, Watanabe K, et all. Case Report Clinical Features of Miller-Fisher Syndrome in Pregnancy. Hindawi 2015
3. Koledade A, OguntayoAO, Abubakar S, Katung G, Shittu S. Clinically Diagnosed Guillain-Barre Syndrome in Pregnancy: Case Report and Review of Literature. Scientific research. 2014
4. Vasudev R, Tina TR. Case report: A Rare case of Guillain-Barré syndrome in pregnancy treated with plasma exchange. Asian journal of tranfusion. 2014 Vol. 8:59-60
5. Inamdar S.A, Inamdar A.H, Chaudhary R, Subhedar V.S. Successful maternal and fetal outcome of Guillain-Barre syndrome complicating pregnancy: a case report. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2013 Sep;2(3):478-479
6. Ahmad Y.S. Saraf Tepi: Sindrom Guillain Barre. Buku ajar neurologi Departemen Neurologi FK UI. 2017 cetakan pertama: 677-688
7. Yilmaz M, Duran E, Topuz C, Kara D, Turgut N, Turkmen U, et all. Clinical Information: Syndrome of inappropriate antidiuretic hormone secretion related to Guillain---Barré syndrome after laparoscopic cholecystectomy. Revista Brasileira De Anestesiologia. Elsevier. 2014: 64(3): 193-198
8. Anandan C, Khuder S.A, Koffman B.M. Prevalence of Autonomic Dysfunction in Hospitalized Patients with GuillainBarre Syndrome. University of Toledo Medical Center. John Wiley & Sons, Inc. 2015
9. Ziganshin R, Ivanova O.M, Lomakin Y.A., Belogurov A.A, Kovalchuck S. I, Azarkin et all. The pathogenesis of the demyelinating form of Guillain-Barre syndrome: proteopeptidomic and immunological profiling of physiological fluids. MCP Papers in Press. 2016
10. Yadav K.K, Adhikari N, Khadka R, Pant A. D and Shah B. Multidrug resistant Enterobacteriaceae and extended spectrum ?-lactamase producing Escherichia coli: a cross-sectional study in National Kidney Center, Nepal. Antimicrobial Resistance and Infection Control. 2015: 4:42
11. Schwartz J, Padmanabhan A, Aqui N, Balogun R, Connelly-Smith L, Delaney M,et all. Guidelines on the Use of Therapeutic Apheresisin Clinical Practice—Evidence-Based Approach fromthe Writing Committee of the American Societyfor Apheresis: The Seventh Special Issue. Journal of Clinical Apheresis. 2016 31:149–338
12. Kalil A.C, Metersky M.L, Klompas M, Muscedere J, Sweeney D.A, Palmer L.B, et all BrozekManagement of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. IDSA Guideline Clinical Infectious Diseases. 2016:63
13. Müllegger R.R, Haring N.S, Glastz M. Skin infections in pregnancy. Clinics in dermatology. 2016: 34(3) 368-377
14. Deane J, Rea M.C, Fouhy F, Stanton C, Ross R.P, Plant B.J. Long-Term Implications of Antibiotic Use on Gut Health and Microbiota in Populations Including Patients With Cystic Fibrosis. The Gut-Brain Axis chapter 11. Elsevier Inc. 2016
15. Jonathan D, Emilie B, Gregory R, Marco V, Philippe H. Neurally adjusted ventilatory assist during weaning from respiratory support in a case of guillain-barré syndrome.Respiratory Care Journal. 2015
16. Ashitha L. Vijayan, Vanimaya, Shilpa, Saikant, Lakshmi, Kartik et all. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. Journal of Intensive care. 2017
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
